In mice experiencing colitis‐related adverse reactions following anti‐CTLA‐4 treatment, supplementation with Bifidobacterium significantly ameliorates colitis symptoms in mice with ATB‐disrupted gut microbiome [218]. Here, CTLA4 is linked to colitis.